Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1420 ARTÍCULOS , VIENDO DEL 616 AL 630

Large-Scale Neural Recording Technologies for Investigating Circuit Dysfunction and Functional Biomarker Discovery in Animal Models of Alzheimer's Disease

Sun D, Wang S, Meng Q, Wang X, Amiri M, Unnithan RR, French C.

Int J Mol Sci. 2026 Jul 20;27(14):6444. doi: 10.3390/ijms27146444.

The human retina in Alzheimer's disease: Pathology, mechanisms, and biomarkers

de Sevilla LP, Majumdar S, Recio B.

Ageing Res Rev. 2026 Oct;121:103275. doi: 10.1016/j.arr.2026.103275. Epub 2026 Jul 28.

Motor performance and its association with Alzheimer's-related biomarkers: a systematic review

Serna MF, Mosquera M, García-Perdomo HA.

Neurol Sci. 2026 Jul 31;47(8):672. doi: 10.1007/s10072-026-09253-4.

Biomarker-Based Diagnosis and Care Pathways for Alzheimer's Disease in the Era of Disease-Modifying Treatments: A Consensus Statement by Belgian Experts

Van Langenhove T, Van Mossevelde S, Miatton M, De Lepeleire J, Bruffaerts R, Bier JC, Segers K, Verschraegen J, Petrovic M, Ventura M, Jedidi H, Beyer I, Mormont E, Vandenberghe R, Delva A, Gilles C, Van Weehaeghe D, Picard G, De Deyn P, Strauss M, Thiery E, Salmon E, Cypers G, Vlaemynck J, Gillis K, Versijpt J, Bjerke M, Sieben A, Hanseeuw B, Engelborghs S, Deryck O; BeDeCo members.

Eur J Neurol. 2026 Aug;33(8):e70668. doi: 10.1111/ene.70668.

Adaptive cascading artificial intelligence for Alzheimer's disease assessment: a clinically oriented narrative review and implementation framework

Hooshmandi S, Rahimi Jaberi K, Kamalov F, Nami M.

Neurol Sci. 2026 Aug 3;47(8):678. doi: 10.1007/s10072-026-09282-z.

Plasma p-tau217 detects Alzheimer's disease co-pathology in cerebral amyloid angiopathy: Comparison to CSF biomarkers in the ANGMAR cohort

Fernández-Lebrero A, Jiménez-Balado J, García-Escobar G, Contador J, Estraguès-Gázquez I, Peraferrer-Montesinos L, Manero-Borràs RM, Gramegna LL, Viles M, Campello AR, Ortiz-Romero P, de Diego M, Del Campo M, Torres-Torronteras J, Jiménez-Moyano E, Blasco-Forniés H, Suárez-Calvet M, Ois A, Puig-Pijoan A, Navalpotro-Gómez I.

Alzheimers Dement. 2026 Aug;22(8):e71709. doi: 10.1002/alz.71709.

Lecanemab use in Chinese patients with Alzheimer's disease: a 12-month multicenter real-world study

Wu H, Chen Q, Fang M, Tang H, Liu H, Liu J, Zhang J, Chi L, Liu S, Xin J, Leng L, Wang P, Chi S, Li Y, Chen J, Zhang L, Zhang J, Ma Q, Wang X, Meng X, Nao J, Li X, Lv Y, Jia Y, Zhao Q, Liu C, Gan J, Zhu J, Song Y, Li H, Fei M, Guo X, Liu J, Peng G, Chen X, Ji Y.

Alzheimers Dement. 2026 Aug;22(8):e71702. doi: 10.1002/alz.71702.

Mechanisms, Biomarkers and Therapeutic Implications of Neuroinflammation in Alzheimer's Disease

Papelian S.

Int J Dev Neurosci. 2026 Aug;86(5):e70168. doi: 10.1002/jdn.70168.

A randomized phase 1b/2 trial of ABBV-916 in adults with early Alzheimer's disease

Lynch SY, Wang Y, Wang D, Bachhav SS, Xiong H, Boiser J, Stage E, Bannon AW, Graff O, Florian H.

Alzheimers Dement. 2026 Aug;22(8):e71715. doi: 10.1002/alz.71715.

Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease

Collins EC, Lu M, Beck R, Hendrix J, Hodsdon ME, Hansson O.

Alzheimers Dement. 2026 Aug;22(8):e71740. doi: 10.1002/alz.71740.

Blood-Based Biomarkers for Alzheimer Disease in Primary Care: The Gap Between Biology and Clinical Utility

Hazan J, Salemme S, Liu KY, Howard R.

Neurology. 2026 Sep 8;107(5):e218403. doi: 10.1212/WNL.0000000000218403. Epub 2026 Aug 12.

Optimized plasma p-tau217 and p-tau217/Aβ42 cutoffs enhance detection of pre-clinical Alzheimer's disease across diverse participants

Piura YD, Aduen PA, Schecter L, Jain MK, Algeciras-Schimnich A, Figdore DJ, Bornhorst J, Petersen RC, Jr CRJ, Graff-Radford NR, Lachner C, Day GS.

Alzheimers Dement. 2026 Aug;22(8):e71763. doi: 10.1002/alz.71763.

Exosome-derived biomarkers as non-invasive tools in stroke, Parkinson's disease, and Alzheimer's disease

Talebi A, Nabili S, Alaei M, Koohsarian P, Doostmohammadi A, Dadashpour M.

Metab Brain Dis. 2026 Aug 20;41(1):189. doi: 10.1007/s11011-026-01947-0.

Multi-Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns

Thakur A, Rana M, Vanjani S, Liou KC, Taliyan R, Nepali K, Yang CH.

Med Res Rev. 2026 Jul;46(4):1173-1229. doi: 10.1002/med.70047. Epub 2026 Apr 19.

Experimental and translational models of Alzheimer's disease: From neurodegeneration to novel therapeutic insights

Khan N, De S, Boddu S, Pravala N.

J Prev Alzheimers Dis. 2026 Apr;13(4):100498. doi: 10.1016/j.tjpad.2026.100498. Epub 2026 Jan 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias